[go: up one dir, main page]

WO1993003619A1 - Bioinsecticide a cibles multiples obtenu a partir de bacillus thuringiensis - Google Patents

Bioinsecticide a cibles multiples obtenu a partir de bacillus thuringiensis Download PDF

Info

Publication number
WO1993003619A1
WO1993003619A1 PCT/US1991/005930 US9105930W WO9303619A1 WO 1993003619 A1 WO1993003619 A1 WO 1993003619A1 US 9105930 W US9105930 W US 9105930W WO 9303619 A1 WO9303619 A1 WO 9303619A1
Authority
WO
WIPO (PCT)
Prior art keywords
bacterium
protoxin
bacillus thuringiensis
gene
chromosomal
Prior art date
Application number
PCT/US1991/005930
Other languages
English (en)
Inventor
Lee A. Bulla, Jr.
Jun Biao Chen
Purnima Ray
Original Assignee
Research Corporation Technologies, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corporation Technologies, Inc. filed Critical Research Corporation Technologies, Inc.
Priority to PCT/US1991/005930 priority Critical patent/WO1993003619A1/fr
Publication of WO1993003619A1 publication Critical patent/WO1993003619A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • C07K14/325—Bacillus thuringiensis crystal peptides, i.e. delta-endotoxins
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
    • A01N63/22—Bacillus
    • A01N63/23—B. thuringiensis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus

Definitions

  • This invention relates to improved Bacillus thuringiensis strains that have broadened insecticidal activity, biologically pure cultures of such strains, and methods of making and using such strains.
  • biopesticidal substances comprise the bacteria, which produce a substance toxic to the pest, i.e.. a toxin.
  • the bacteria may be present with or without a bacterial growth medium or a carrying medium.
  • the substances may be directly applied to the plants, and they are typically less harmful to non-target organisms and to the environment than their chemical counterparts.
  • B.t. Bacillus thuringiensis
  • B.t. Bacillus thuringiensis
  • B.t. is a rod-shaped, aerobic, spore-forming microorganism which produces proteins known as protoxins.
  • the protoxins are deposited in B.t. as crystalline structures, or they are present in B.t. as part of the spore coat.
  • These protoxin crystals are pathogenic to a variety of sensitive insects. However, the crystals are only active, i.e. , pathogenic in the insect, after ingestion. They are cleaved in the insect's gut to produce the active toxin. Therefore, B.t. is harmless to plants and other nontargeted insects or animals.
  • B.t. Different strains of B.t. produce different crystals, which are toxic to different types of insects. Generally, a single strain of B.t. produces a protoxin for a certain type of pests. It would therefore be advantageous to construct a strain of B.t. which would be toxic to a variety of pests and thereby limit the amount of biopesticides necessary for control of pests. Construction of a bacterial strain for a variety of pests would also allow for the specific design of an insecticide to the varying needs of different geographical areas.
  • European Patent Application 0202470 of Abbott Laboratories discloses a toxin crystal protein which is located on the plasmid of Bacillus thuringiensis subspecies kurstaki (B.t.k.) . This endotoxin is active against lepidopteran insects and is expressed in a B.s. strain following channeling into Escherichia coli (E. coli) .
  • Japanese Abstract JP63017687 discloses expression of a B.t.k. toxin gene in B.s.
  • the B.t.k. protoxin HD-1 gene is cloned, channelled through E___. coli and incorporated in a B.s. strain by plasmid transfer.
  • WO 91/01087 discloses a B.t. hybrid gene which is obtained by in vivo recombination of the hypervariable regions of the genes coding for the B.t. toxin.
  • the preferred pesticidal toxin producing genes are HD-1 Dipel and the HD-73 from slightly different strains of B.t.k. Both of the above-mentioned genes are cloned in a plasmid vector which is then introduced into a strain of E_j_ coli for production of the pesticidal toxins.
  • the application also discloses several different strains of B.t.. including Bacillus thuringiensis subspecies israelensis (B.t.i.
  • a B.t. strain that has an expanded insect host range by virtue of containing at least one acquired protoxin gene of chromosomal origin that is stably integrated into the microorganism's genome and that is adequately expressed so as to provide sufficient quantities of protoxin for insecticidal activity.
  • the present invention overcomes the problems in the prior art by constructing a Bacillus thuringiensis strain having an expanded insect host range using a novel method for genetically transforming gram-positive spore-forming bacilli as well as gram-negative bacteria.
  • the method involves the use of a single colony mating technique. The technique allows for the stable incorporation and expression of chromosomal protoxin genes in B.t. strains.
  • Another object of the invention is to provide an insecticide which contains the Bacillus thuringiensis bacterium having an expanded host range.
  • a still further object of the invention is to provide a method of controlling insects using the Bacillus thuringiensis bacterium having an expanded host range.
  • Yet another object of the invention is to provide a transformed B.s. bacterium which stably incorporates and expresses a recombinant chromosomal protoxin gene of a B.t. bacterium.
  • Another object of the invention is to provide a method for transforming a B.s. bacterium resulting in the stable incorporation and expression of a recombinant chromosomal Bacillus thuringiensis protoxin gene.
  • a still further object of the invention is to provide a method of transferring DNA from a donor bacterium to a recipient bacterium which combines the selection and conjugation steps into a single step.
  • a still further object of the invention is to provide expression vectors containing Bacillus thuringiensis protoxin genes and host cells transformed by such genes and vectors.
  • the present invention provides a Bacillus thuringiensis strain having an expanded insect host range.
  • the strain is a genetically modified Bacillus thuringiensis bacterium that produces a protoxin by expression of a foreign chromosomal protoxin gene.
  • the bacterium also produces a second protoxin by expression of a gene that differs from the foreign chromosomal protoxin gene.
  • a gene that differs from the foreign chromosomal protoxin gene occurs naturally in the strain that is the recipient for the foreign chromosomal protoxin gene.
  • the preferred bacterium will have the combined insecticidal activity of both the recipient strain and the donor strain. Most preferably, such activity is directed against lepidopteran insects and dipteran insects.
  • the genetically modified Bacillus thuringiensis bacterium further produces a third protoxin by expression of a gene that differs from the first and second protoxins.
  • This third gene may be a foreign chromosomal protoxin gene or a protoxin gene of plasmid origin. This permits the modified bacterium to have even further expanded activity, such as against coleopteran insects.
  • the genetically modified bacteria of the invention are used as biopesticides.
  • the insecticide comprises a mixture of an insecticidally effective amount of one or more of the genetically modified B.t. strains in a pesticidally acceptable carrier.
  • the invention further provides a method of controlling or mitigating insect pests by applying an effective amount of the insecticide of the invention to the pests or their habitats.
  • the invention further comprises a method of making the genetically modified bacteria.
  • the method comprises using genetic engineering (recombinant DNA) techniques to transform an intermediate microorganism, preferably Bacillus subtilis, with the foreign chromosomal protoxin gene.
  • the chromosomal protoxin gene is then transferred from the transformed Bacillus subtilis to the recipient Bacillus thuringiensis bacterium by our novel single colony mating technique.
  • the Bacillus subtilis bacterium is transformed by the steps of: (1) ligating a Bacillus thuringiensis chromosomal protoxin gene into a shuttle vector to produce an expression vector; (2) transferring the expression vector into a Bacillus subtilis bacterium by protoplast transformation; and (3) recovering the transformed Bacillus subtilis bacterium.
  • the expression vector is first replicated in a compatible host, such as Escherichia coli. before being transferred into the Bacillus subtilis bacterium.
  • the single colony mating technique comprises several steps. First, the recipient bacterium, in this case the Bacillus thuringiensis that is being genetically modified, is placed onto a solid growth medium that contains at least two different antibiotics. The recipient bacterium contains a gene encoding resistance to one of the antibiotics. Second, single colonies of the donor bacterium are separately inoculated onto the medium. The donor bacterium contains a gene encoding resistance to the other of the two antibiotics, and the resistance gene is part of the DNA being transferred. Third, the agar plate is incubated for a sufficient period of time and under appropriate, standard conditions to effect transfer of the DNA from the donor bacterium to the recipient bacterium.
  • transcipient colony is selected after the incubation by selecting a colony that grows on the medium. Only those transcipient bacteria; i.e. those that contain the DNA from the donor, are able to grow because only they will be resistant to both antibiotics. Preferably, transcipient colonies are further evaluated for insecticidal activity, particularly activity showing the expression of the protoxin chromosomal gene.
  • Figure 1 is an agarose gel electrophoretogra of pUW39 isolated from transformed J3__ coli.
  • Lane l contains pUW39 DNA digested with the restriction enzyme, EcoRI.
  • Lane 2 contains pHV33 DNA digested with EcoRI.
  • Figure 2 is an electrophoretic and Southern hybridization analysis of pUW39 isolated from transformed B.s.
  • Panel A is an agarose gel electrophoretogram of EcoRI digest of Charon 4A DNA (lane 1) , pHV33 DNA (lane 2) , and pUW39 DNA (lanes 4-6) .
  • Lane 3 is a partial digest of pUW39.
  • Panel B is an autoradiogram of the 32 P-labeled 4.6 kbp DNA fragment hybridized to the EcoRI digest contained in A.
  • Figure 3 is an Ouchterlony double diffusion immunological analysis of transformed B.s. containing the 130 kDa protoxin gene of B.t.k.
  • Well 1 contains alkaline solubilized cell extract of well-type B.t.k.
  • Well 2 contains alkaline solubilized cell extract of B.s. transformed with pUW39.
  • Well 3 contains alkaline solubilized cell extract of untransformed wild-type B.s.
  • Well 4 contains B.t.k. toxic protein antibody.
  • Figure 4 is an Ouchterlony double diffusion immunological analysis of B.t.i. transformed with pUW39 containing the 130 kDa protoxin gene of B.t.k.
  • Wells A and F contain alkaline solubilized B.t.i. toxic protein from wild-type B.t.i.
  • Well B contains B.t.i. toxic protein antibody.
  • Wells C and D contain alkaline solubilized B.t.k. toxic protein from wild-type B.t.k.
  • Well E contains B.t.k. toxic protein antibody.
  • Well G contains alkaline solubilized toxic protein from B.t.i. transformed with pUW39.
  • Figure 5 is an immunochemical detection of 130 kDa protoxins in toxic proteins from wild-type B.t.i.. B.t.k. and B.t.i. transformed with pUW39.
  • the invention relates to a genetically modified Bacillus thuringiensis bacterium that produces a protoxin by expression of a foreign chromosomal protoxin gene.
  • foreign chromosomal protoxin gene means a gene of chromosomal origin (i.e., a gene in the chromosome) in a Bacillus thuringiensis strain, which gene is not found in the Bacillus thuringiensis recipient strain and which codes for a protein protoxin (also known as a delta-endotoxin) in the donor strain.
  • the foreign gene is stably incorporated into the genome of the recipient (host) bacterium. That is, it remains incorporated in the progeny of the modified bacterium without the need for antibiotic pressure.
  • the gene may be incorporated into the chromosome of the recipient bacterium or into a plasmid in the recipient bacterium.
  • the gene expresses at detectable levels, and such expression is stable. That is, the expression of the gene in the recipient strain provides sufficient protoxin for insecticidal activity in standard insect bioassays used to determine such activity, and any variation in the level of expression is within the range normally found in the expression of protoxins by naturally occurring Bacillus thuringiensis strains.
  • the LC-50 values for the transcipient strain are virtually the same as those of the parental strains.
  • the recipient strain contains a second protoxin gene that differs from the foreign gene.
  • the second gene most preferably occurs naturally in the recipient strain (i.e., it is inherent), but it could also be an acquired gene incorporated into the genome of the recipient strain by various genetic techniques. In the latter case, the gene could be of chromosomal origin in the donor B.t.. or it could be of plasmid origin in the donor B.t. Therefore, the genetically modified bacterium preferably produces two different protoxins, thereby providing activity against types of insects that neither the recipient bacterium nor the donor bacterium individually had activity against.
  • the recipient bacterium preferably produces a protoxin that is active against dipteran insects, such as mosquitos, black flies, and tsetse flies, and the donor bacterium provides a chromosomal gene that codes for a protoxin against lepidopteran insects, such as cabbage looper, tobacco hornworn, spruce budworm, and corn rootworm.
  • the recipient strain may be any Bacillus thuringiensis strain.
  • the recipient is a strain of Bacillus thuringiensis subspecies israelensis (B.t.i.) .
  • Such strains are well known and widely available to those skilled in the art. They naturally produce a protoxin that has activity against dipteran insects.
  • the donor strain is any Bacillus thuringiensis strain that naturally contains one or more chromosomal protoxin genes.
  • the donor strain is a strain of Bacillus thuringiensis subspecies kurstaki (B.t.k.) .
  • This subspecies contains a chromosomal protoxin gene that encodes a protoxin with activity against lepidopteran insects.
  • the gene is from a strain that produces the known 130 kilodalton (kDa) lepidopteran protoxin.
  • the following strains may be used as the source of chromosomal protoxin genes: Bacillus thuringiensis subspecies berliner. tolworthi , aizawaii. morrosonii. and galleriae.
  • the genetically modified Bacillus thuringiensis bacterium of the invention comprises a bacterium that has the insecticidal activity of the bacterium deposited with the American Type Culture Collection (ATCC) under Accession No. 68665 and derivatives and mutants thereof that retain the insecticidal activity.
  • ATCC American Type Culture Collection
  • This strain was deposited with the ATCC, 12301 Parklawn Drive, Rockville, Maryland 20852 U.S.A. under the Budapest Treaty on August 13, 1991.
  • This preferred strain is a B.t.i. strain that naturally contains a protoxin against dipteran insects.
  • the strain has been modified by stable insertion of a chromosomal gene from B.t.k.
  • This strain also contains the preferred expression vector of the invention, which is the plasmid designated pUW39.
  • mutants and derivatives that still have the insecticidal activity of the parent strain.
  • mutants or derivatives may have enhanced expression of one or both of the strain's protoxins or may have different nutritional requirements.
  • they are derived from the strain and have lepidopteran and dipteran activity, they are within the scope of this invention.
  • the preferred Bacillus thuringiensis bacterium that produces two different protoxins has been further modified to produce a third protoxin by expression of a gene that differs from the first and second protoxin genes.
  • the third protoxin gene may be from any Bacillus thuringiensis bacterium that contains the gene of interest.
  • this third protoxin is active against coleopteran insects, such as Colorado potato beetle and pine bark beetle.
  • the gene for such protoxin may be obtained from any Bacillus thuringiensis strain having anti-coleopteran activity, but it is preferably obtained from a Bacillus thuringiensis subspecies tenebrionsis (B.t.t) strain.
  • the third protoxin gene may be of chromosomal or plasmid origin, and it may be stably integrated into the chromosome or a plasmid of the previously modified Bacillus thuringiensis bacterium. Accordingly, the alternative preferred modified Bacillus thuringiensis bacterium produces protoxins against lepidopteran, dipteran, and coleopteran insects.
  • the preferred bacteria of the invention are described as a bacterium having anti-dipteran and anti- lepidopteran activity and another bacterium having anti- dipteran, anti-lepidopteran, and anti-coleopteran activity.
  • bacterium having anti-dipteran and anti- lepidopteran activity and another bacterium having anti- dipteran, anti-lepidopteran, and anti-coleopteran activity.
  • modified bacteria having anti-dipteran and anti-coleopteran activity or anti-lepidopteran and anti-coleopteran activity include modified bacteria having anti-dipteran and anti-coleopteran activity or anti-lepidopteran and anti-coleopteran activity.
  • the Bacillus thuringiensis bacteria of the invention are made by a combination of standard genetic engineering techniques and a novel technique that we call single colony mating.
  • the genetic engineering (recombinant DNA) techniques are among those disclosed in Maniatis et al.. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory (1982) , incorporated herein by reference.
  • the genetic engineering techniques are used to transform another bacterium, preferably Bacillus subtilis. with the protoxin encoding gene that is ultimately intended for the recipient Bacillus thuringiensis strain. The gene is then transferred from the transformed Bacillus subtilis to the recipient Bacillus thuringiensis by our single colony mating technique.
  • the invention also comprises a transformed Bacillus subtilis bacterium that contains a chromosomal protoxin gene of a Bacillus thuringiensis bacterium, wherein the protoxin gene is expressed in the transformed Bacillus subtilis.
  • the protoxin gene is the previously discussed gene from B.t.k.
  • the transformed Bacillus subtilis bacterium may also contain a second gene that codes for a different protoxin.
  • This second gene may also be of chromosomal origin or plasmid origin. It may be on an acquired plasmid, i.e., on a plasmid that has been transformed into the Bacillus subtilis.
  • the second gene encodes a protoxin having anti-coleopteran activity.
  • the chromosomal protoxin gene of interest is obtained from the appropriate Bacillus thuringiensis strain by known techniques, primarily utilizing restriction enzymes.
  • the gene is preferably cloned into a known cloning vector, such as Charon 4A Lambda Phage. It is then ligated into a shuttle vector.
  • the cloned protoxin gene is preferably purified prior to ligation into the vector.
  • the preferred shuttle vector is the commercially available plasmid pHV33, which was made by fusing pBR322 and pC194.
  • the further ligation of the gene into the shuttle vector in proper orientation and correct reading frame for expression produces an expression vector for expressing the gene in the appropriate host cell.
  • the preferred expression vector is the plasmid pUW39, which is the plasmid formed when the gene for the 130 kDa lepidopteran protoxin from B.t.k. is ligated into the shuttle vector pHV33.
  • the expression vector is then replicated. This is accomplished by transformation of the expression vector into a compatible host microorganism. With pUW39, the preferred host is E. coli. Other host cells may be chosen by persons skilled in the art, once given the teachings contained herein and the desired expression vector.
  • the vector is put into the E. coli by standard transformation techniques. The E. coli is cultured under standard conditions for a sufficient period of time known or determinable by those skilled in the art to provide for the desired replication of the expression vector.
  • the expression vector is then recovered from the E. coli by known techniques and transferred into Bacillus subtilis by protoplast transformation, using standard techniques, whereby the transferred genetic material is incorporated into the B. subtilis genome and expressed by the transformed bacterium.
  • Preferably, subclones of the transformed B. subtilis are then identified and confirmed by standard immunological analyses and insect bioassays. Transformation of the B.s. is not limited to protoplast transformation as other known methods, such as electroporation, may be used.
  • the expression vector is then transferred from the intermediate bacterial strain to the recipient Bacillus thuringiensis strain by use of the single colony mating technique. This technique combines the previously separate steps of conjugation and selection into a single step.
  • the recipient bacterium is placed onto a solid growth medium, preferably an agar plate, containing two different antibiotics.
  • the recipient strain is chosen or genetically engineered so that it contains a gene encoding resistance to one of the antibiotics.
  • Single colonies of the donor bacterium, in this case the transformed Bacillus subtilis, are separately inoculated onto the medium so that they come into contact with the recipient strain.
  • the donor strain contains a gene encoding resistance to the second of the two antibiotics in the medium, i.e., the antibiotic to which the recipient bacterium is not resistant. This second antibiotic resistance gene is on the expression plasmid.
  • significant quantities of the donor and recipient bacteria are first grown up in liquid medium that contains no antibiotics.
  • the solid medium is then incubated for a sufficient period of time and under appropriate conditions known to those skilled in the art or determinable by those skilled in the art, once given the teachings contained herein, to effect a transfer of the expression plasmid from the donor bacterium to the recipient bacterium.
  • the expression vector may integrate with the chromosome of the recipient bacterium or it may remain as a separate plasmid in the recipient bacterium.
  • Colonies of transcipient bacteria are identified and selected after incubation by simply selecting a colony that grows on the medium and isolating the colony.
  • the transcipient colonies will comprise bacteria resistant to both antibiotics.
  • the identified transcipient colonies are further evaluated by testing them for insecticidal activity, using standard bioassays.
  • sequence of placing the bacteria colonies in the single colony mating technique is not limited to the sequence of the donor colony placed on the recipient colony. Transformation would also occur if the recipient colony is placed on the donor.
  • the single colony mating technique of the invention is not limited to Bacillus subtilis and Bacillus thuringiensis. It can be applied to transfer DNA from any donor bacterium to any recipient bacterium, including gram- negative bacteria as well as gram-positive bacteria, provided that the recipient bacteria contain a genotypic or phenotypic marker, such as a resistance gene to one of the antibiotics in the medium, and the DNA being transferred from the donor bacterium contains a different genotypic or phenotypic marker, such as a gene for antibiotic resistance to the second antibiotic in the medium. Additional genotypic or phenotypic markers may also be used so long as all such characterizing markers are not contained in either the donor bacteria or the recipient bacteria.
  • a marker different from antibiotic resistance such as an ability or inability to metabolize a particular nutrient
  • at least two markers are used.
  • the donor strain will have one, and the recipient strain will have the other.
  • the medium will have or lack the appropriate nutrient so that only the transcipient can grow on it.
  • the methods discussed above can be used to add additional toxic activity as well as other phenotypic attributes to the recipient strain, thereby creating a further genetically modified strain that has additionally enhanced insecticidal or other types of activities.
  • One or more additional chromosomal or plasmid protoxin genes can be added.
  • the gene may be identical to one previously added, thereby enhancing the newly created insecticidal activity, but not increasing the range of the transcipient, or a protoxin gene that differs from those already in the transcipient can be added.
  • the preferred transcipient of the invention is further genetically modified by the addition of a protoxin gene that encodes a protoxin having activity against coleopteran insects.
  • the additional gene or genes need not be added by the single colony mating of transformed Bacillus subtilis with the first transcipient. Instead, the gene may be added by known techniques, such as conventional DNA transformation, protoplast fusion, and electroporation.
  • the biopesticide comprises an effective amount of one or more of the modified strains in a pesticidally acceptable carrier.
  • pesticidally acceptable carrier means a carrier substance for the bacteria whose effects, if any, on the activity of the bacteria, are acceptable to persons skilled in the art and whose effects, if any, on humans, plants, and other living organisms are also acceptable to persons skilled in the art.
  • the formulation for use of the biopesticide is not limited to any specific type of formulation or amount. For example, a biopesticide formulation may be administered as a dust or wettable powder, using methods known in the art.
  • the amount of bacteria in the mixture will vary depending upon the type of pests for which the biopesticide is to be used. What is necessary, however, is that an effective amount of the biopesticide be used in the mixture. Usually the effective amount is between 0.1 to 99% with the remaining composition made up of the carriers or other inactive ingredients. The effective amount can be determined by persons skilled in the art, given the teachings contained herein.
  • the biopesticide is in the form of a suspension concentrate.
  • the bacteria may be added to a suitable carrier as a dust or in a suspension, for instance a suspension in oil or water.
  • suitable carriers may be either solid or liquid and may correspond to substances normally used in the agricultural field. Such carriers may include but are not limited to natural or regenerated mineral substances, solvents, dispersents, wetting agents, tackifiers, binders or fertilizers.
  • the formulations are prepared in a manner known in the art, such as by mixing or grinding the active ingredients with extenders, i.e., solvents, solid carriers or surfactants. The formulations are then applied to the target crops or to the habitats of the targeted insects in an effective amount.
  • the effective dosage based upon the LC-50 value, can be determined by persons skilled in the art, based on the teachings contained herein.
  • the process of the invention produces new strains having a modified activity. It also provides the ability to tailor a specific strain for specific geographical areas, or ecological niches.
  • the plasmid pHV33 is a hybrid plasmid which has been previously constructed by the fusion of pBR322, USB catalog number 14386, and pC194, Ehrilich, S.D., et al., PNAS, 74:1680-1682 (1988), incorporated herein by reference.
  • the plasmid pUW39 was then introduced into Escherichia coli HB101 for replication by conventional straightforward transformation.
  • Figure 1 shows that the 4.6 kbp fragment, which is equivalent to the Charon 4A fragment, was present in the pUW39 isolated from
  • the recombinant plasmids were then isolated and transferred into Bacillus subtilis BD224 by protoplast fusion. Subclones in the Bacillus subtilis were identified and confirmed by known immunological analyses and insect bioassays.
  • Figures 2 and 3 show the presence of the B.t.k. protoxin gene, which is contained in the constructed plasmid pUW39.
  • Figure 2 shows that hybridization occurred with the 4.6 kbp DNA that contains the 130 kDa protoxin gene of B.t.k. (lane 1, arrow) , the dimer consisting of the 4.6 kbp fragment and pHV33 (lane 3, arrow) and to the 4.6 kpb fragment of pUW39 (lanes 4-6, arrow) .
  • Figure 3 shows that the B.t.k. toxic protein antigen (well 1) reacted strongly with B.t.k.
  • the cloned pUW39 containing the B.t.k. protoxin gene was introduced into B.t.i 1884, provided by H. deBarjec, Pasteur Institute, by single colony mating. Prior to and after genetic transfer, the B.t.i. recipient strain contained a gene encoding a protoxin having insecticidal activity against dipteran insects.
  • the single colony mating method was carried out on an LB solid medium.
  • a LB liquid medium was constructed according to the following recipe prior to the mating step. The following ingredients were combined:
  • Solid LB medium was formed by adding 15 grams of agar to one liter of liquid LB medium.
  • a 1% innoculum of the recipient B.t.i. strain was grown in liquid LB medium for 24 hours and was then placed into fresh liquid LB medium and incubated for 6 hours. One/tenth ml of the 6 hour culture was then spread evenly onto an LB solid medium which also contained streptomycin, chloramphenicol and casein hydrolysate. Prior to genetic transfer, the recipient B.t.i. strain contained a gene encoding resistance to streptomycin.
  • Bacillus subtilis containing pUW39 was spread onto a second LB agar plate which contained no antibiotics and was incubated for 24 hours. Single colonies of the Bacillus subtilis were isolated and inoculated onto the surface of the first LB agar plate containing the antibiotics and the B.t.i.
  • the first agar plate had been previously divided into 50 sections and a single colony of B.s. was placed in each section.
  • the agar plate containing both strains was then incubated for 48 hours at 30°C to effect genetic transfer.
  • the B.s. transferred the genetic material originally from B.t.k.. which included the gene encoding resistance to chloramphenicol.
  • the transcipient strain could grow in the presence of the antibiotics whereas the donor strain, i.e.. B.s. and the recipient strain, i.e.. B.t.i. could not grow due to the absence of both antibiotic resistances.
  • Transcipient colonies were selected and were then grown several times in the presence of both antibiotics and were then bioassayed for their immunological and insecticidal activities.
  • the immunoassays used were Ouchterlony double diffusion and Western blot analyses and the insect bioassays involved testing activity against tobacco hornworm larvae, (lepidopteran) and mosquito larvae, i.e.. anopheles and aedes spp. (dipteran) insects.
  • the LC-50 values for tobacco hornworm larvae and aedes larvae were 1.0 micrograms/cm 2 for 5 ml medium and 0.25 micrograms/20 ml, respectively. These values were virtually identical to those values of the parental B.t.k. and B.t.i. strains when tested separately against the same insects under identical conditions.
  • Figures 4 and 5 depict the results of the immunoassays.
  • Figure 4 an Ouchterlony and im unoassay, shows that the B.t.i. and B.t.k. toxic protein antigens (wells A and D) reacted strongly with the respective B.t.i. and B.t.k. toxic protein antibodies (wells B and E) creating intense precipitin bands between wells A and B and wells D and E.
  • alkaline solubilized toxic protein crystals of B.t.i. transformed with pUW39 that contains both the B.t.i. and B.t.k. protoxin genes (well A) reacted with B.t.i. and B.t.k.
  • panel 1 shows that the 130 kDa B.t.i. protoxin, as well as several other immunoreactive polypeptides, was present in both the transformed and wild- type B.t.i. strains (lanes A and B, respectively) whereas it was absent in wild-type B.t.k. (lane C) .
  • Panel 2 shows that transformed B.t.i. (lane A) , wild-type B.t.i. (lane B) and wild-type B.t.k. (lane C) contained the 130 kDa protoxin as well as other immunoreactive polypeptides.
  • Both B.t.i. strains (lanes A and B) also contained a 28 kDa polypeptide whereas B.t.k. (lane C) did not.
  • Panel 3 shows that the 130 kDa B.t.k. protoxin was present in the transformed B.t.i. (lane A) and wild-type B.t.k. (lane C) strains but not in wild-type B.t.i. (lane B) .
  • Table 1 depicts the insecticidal activity of the transformed B.s. against the silkworm larva Bombvx mori. All cells were grown until fully sporulated and then were lysed mechanically. Equal dry weights of cell extracts were treated with 2N NaOH (pH 12) for 5 hours, the insoluble cell debris was removed by centrifugation and the resulting supernatants were dialyzed to pH 8.0. Equal volumes of the supernatants were spread evenly onto equal surface areas of mulberry leaves and 2nd instar larvae of B. mori were released singly onto the mulberry leaves. Mortality counts were taken at 72 hours.
  • transformed B.s. containing the B.t.k. 130 kDa protoxin gene was quite effective at killing silkworm larvae compared to wild-type B.t.k. Neither wild-type B.s. or B.t.i. 1884 had any toxic effect and the silkworm larvae developed to full maturation.
  • Table 2 depicts the insecticidal activity of the transcipient B.t.i. against the silkworm Bombyx mori and the mosquito Anopholes spp. All cells tested were grown and handled as described in Table 1. Bioassays with B. mori also were done as in Table 1.
  • Mosquito bioassays were performed with 2nd instar Anopholes spp. larvae. Single larvae were placed in individual cups holding water plus equal amounts of supernatant to a volume of 20 ml. Twenty larvae were used to determine toxicity of each respective supernatant. Mortality counts were taken at 72 hours.
  • the transcipient B.t.i. containing the 130 kDa B.t.k. protoxin gene killed silkworm larvae as effectively and efficiently as did wild-type B.t.k.. while retaining its capacity to kill mosquito larvae as well.
  • Table 3 depicts the obtained LC-50 values which show that the new transcipient strain contained protoxins resulting in insecticidal activity against both lepidopteran (i.e., tobacco hornworm, manduca sexta) and dipteran (i.e., aedes aegypti) insects at levels comparable to the wild parental strains.
  • u stands for micro.
  • a second example of the invention involves forming a bacterium which contains insecticidal activity against dipteran, lepidopteran, and coleopteran insects.
  • the strain of bacterium described above is first formed and into such strain is introduced a coleopteran toxic gene from Bacillus thuringiensis subsp. tenebrionis.
  • the gene cloned in E. coli encoding for the coleopteran protoxin is first isolated from E_j. coli that contains the toxin gene in a plasmid.
  • the fragment is then ligated into the vector pHV33. Once the gene fragment is ligated into vector pHV33, that recombinant plasmid is then incorporated into the above-obtained B.t.i. strain of Example 1 by electroporation.
  • An alternative method is to first transfer the recombinant plasmid containing the B.t.t. gene into B.s. by protoplast transformation as described in Example 1 and then transfer the gene from B.s. into B.t.i. by the single colony mating described above. If the single colony mating method is used, an additional antibiotic must be selected and placed on the agar plate. The antibiotic must be selected such that a gene encoding for resistance would be transferred from Bacillus subtilis to the recipient strain along with the gene coding for the coleopteran protoxin.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Des souches de Bacillus thuringiensis ayant une activité insecticide élargie sont synthétisées par l'ingénierie génétique et une technique de conjugaison à une seule colonie. Ladite technique de conjugaison permet l'expression de gènes de protoxine chromosomique dans la souche réceptrice. La souche préférée est une sous-espèce israelensis de Bacillus thuringiensis qui a été génétiquement modifiée par l'incorporation stable d'un gène de protoxine de la sous-espèce kurstaki de Bacillus thuringiensis.
PCT/US1991/005930 1991-08-19 1991-08-19 Bioinsecticide a cibles multiples obtenu a partir de bacillus thuringiensis WO1993003619A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/US1991/005930 WO1993003619A1 (fr) 1991-08-19 1991-08-19 Bioinsecticide a cibles multiples obtenu a partir de bacillus thuringiensis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1991/005930 WO1993003619A1 (fr) 1991-08-19 1991-08-19 Bioinsecticide a cibles multiples obtenu a partir de bacillus thuringiensis

Publications (1)

Publication Number Publication Date
WO1993003619A1 true WO1993003619A1 (fr) 1993-03-04

Family

ID=22225752

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1991/005930 WO1993003619A1 (fr) 1991-08-19 1991-08-19 Bioinsecticide a cibles multiples obtenu a partir de bacillus thuringiensis

Country Status (1)

Country Link
WO (1) WO1993003619A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994025611A1 (fr) * 1993-04-23 1994-11-10 Sandoz Ltd. Segment d'adn d'integration comprenant un gene codant une proteine insecticide
KR19990082013A (ko) * 1996-01-26 1999-11-15 스티븐 에프. 웨인스톡 바실러스 투린지엔시스 인테그란트의 제조
US6280720B1 (en) 1993-07-15 2001-08-28 Valant Biosciences, Inc. Formation of and methods for the production of large Bacillus thuringiensis crystals with increased pesticidal activity

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695455A (en) * 1985-01-22 1987-09-22 Mycogen Corporation Cellular encapsulation of pesticides produced by expression of heterologous genes
US4771131A (en) * 1985-08-16 1988-09-13 Mycogen Corporation Cloning and expression of Bacillus thuringiensis toxin gene encoding a protein toxic to beetles of the order Coleoptera
US4797279A (en) * 1985-10-30 1989-01-10 Sandoz Ltd. Insecticidal hybrid bacteria from b.t. kurstaki and b.t. tenebrionis

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695455A (en) * 1985-01-22 1987-09-22 Mycogen Corporation Cellular encapsulation of pesticides produced by expression of heterologous genes
US4771131A (en) * 1985-08-16 1988-09-13 Mycogen Corporation Cloning and expression of Bacillus thuringiensis toxin gene encoding a protein toxic to beetles of the order Coleoptera
US4797279A (en) * 1985-10-30 1989-01-10 Sandoz Ltd. Insecticidal hybrid bacteria from b.t. kurstaki and b.t. tenebrionis

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF BACTERIOLOGY, 166, No. 3, issued June 1986, L. THORNE et al., "Structural Similarity Between the Lepidoptera and Diptera-specific Insecticidal Endotoxin Genes of Bacillus Thuringiensis Subs. "Kurstaki" and "Israelensis"", pages 801-811. *
JOURNAL OF MOLECULAR BIOLOGY, Volume 191, issued August 1986, E.S. WARD et al., "Bacillus Thuringiensis Var. Israelensis Delta-Endotoxin Cloning and Expression of the Toxin in Sporogenic and Asporogenic Strains of Bacillus Subtilis", pages 13-22. *
MICROBIOLOGICAL REVIEWS, Volume 53, No. 2, issued June 1989, HOFTER et al., "Insecticidal Crystal Proteins of Bacillus Thuringiensis", pages 242-255. *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994025611A1 (fr) * 1993-04-23 1994-11-10 Sandoz Ltd. Segment d'adn d'integration comprenant un gene codant une proteine insecticide
AU685516B2 (en) * 1993-04-23 1998-01-22 Novartis Ag Integrative DNA segment comprising gene encoding insecticidal protein
US6280720B1 (en) 1993-07-15 2001-08-28 Valant Biosciences, Inc. Formation of and methods for the production of large Bacillus thuringiensis crystals with increased pesticidal activity
KR19990082013A (ko) * 1996-01-26 1999-11-15 스티븐 에프. 웨인스톡 바실러스 투린지엔시스 인테그란트의 제조

Similar Documents

Publication Publication Date Title
EP0602064B1 (fr) Nouveaux microorganismes et insecticide
US5187091A (en) Bacillus thuringiensis cryiiic gene encoding toxic to coleopteran insects
US5024837A (en) Coleopteran active microorganisms, related insecticide compositions and methods for their production and use
US5888976A (en) Bacillus thuringiensis isolates and toxins
US5126133A (en) Bacillus thuringiensis isolate active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins
US5164180A (en) Bacillus thuringiensis isolates active against lepidopteran pests
US5596071A (en) Bacillus thuringiensis toxins active against hymenopteran pests
DE69232098T2 (de) Neues koleopterenaktives isolat von bacillus thuringiensis und gene die für koleopterenaktive toxine kodieren
JP2531913B2 (ja) バシルス チュリンギエンシス（Ｂａｓｉｌｌｕｓ ｔｈｕｒｉｎｇｉｅｎｓｉｓ） ｃｒｙＩＩＩＣ（ｂ）毒素遺伝子及び甲虫類昆虫に毒性のタンパク質
AU709112B2 (en) Bacillus thuringiensis isolates active against cockroaches
US5356623A (en) Bacillus thuringiensis cryET1 toxin gene and protein toxic to lepidopteran insects
EP0570506B1 (fr) Isolats de bacillus thuringiensis
WO1993003619A1 (fr) Bioinsecticide a cibles multiples obtenu a partir de bacillus thuringiensis
US5804180A (en) Bacillus thuringiensis strains showing improved production of certain lepidopteran-toxic crystal proteins
WO1998015170A1 (fr) Proteines cristallines chimeres toxiques pour des lepidopteres
US5359048A (en) Polynucleotide encoding a toxin with activity against coleopterans
US5616495A (en) Bacillus thuringiensis gene encoding hymenopteran-active toxins
Kaur et al. Bacteria as biocontrol agents of insects
Kaur et al. Applied Mycology Laboratory
MXPA99000653A (en) Bacillus thuringiensis scapes that show improved production of certain crystal proteins toxicas to lepidopt
EP1065275A1 (fr) Nouveaux isolats de bacillus thuringiensis présentant une activité contre les hyménoptères nuisibles et gènes codant des toxines agissant contre les hyménoptères

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA US

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: CA